SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in...

NEWS: Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016 Healthcare Conference, being held in San Francisco, Jan. 11-14. The conference, which is now in its 34th year, is an invitation-only event intended to create an environment of collaboration by bringing together stakeholders in the corporate, investor and financial sectors to learn about and explore market and sector trends.

NEW YORK, N.Y. and LONDON, U.K. -- With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years. To address this alarming issue, Eularis announces the availability of its new report, "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?"

SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) announced today that its lead product, Rexin-G, has been granted Fast Track designation by the U.S. Food...

SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) today announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out...

WASHINGTON, D.C. -- Belvidere Pharmacy is the first pharmacy in the state of New Jersey to earn the Pharmacy Compounding Accreditation Board's Seal of Accreditation - a new system of standards created by some of the leading organizations in pharmacy. The accreditation demonstrates that Belvidere Pharmacy meets the highest quality and safety standards in its profession.

SAN MARINO, Calif. -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma...

NEWS: Philosys, Inc., the maker of Gmate(R) products, announced today that the U.S. Food and Drug Administration (FDA) has approved clearance for the Gmate SMART Blood Glucose Monitoring System and App for Android(TM). The Gmate SMART is a small, portable blood glucose meter that plugs into the headphone jack of a smartphone and provides fast and accurate blood glucose test results.

LOS ANGELES, Calif. -- Full Performance Fitness Inc. has signed a deal with new Detroit Red Wings defenseman Garrett Stafford. Garrett is a Los Angeles native, but played in the northeast growing up. He finished the regular season as the Sharks top scoring defenseman and T-8th among AHL blueliners with 41 points.